Sexually dimorphic effect of the Val66Met oolymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 1, 2010, Pages 235-242

  Fukumoto, Noriko ^a   Fujii, Takashi ^a   Combarros, Onofre ^b   Kamboh, M Ilyas ^c   Tsai, Shin Jen ^d   Matsushita, Sachio ^e   Nacmias, Benedetta ^f   Comings, David E ^g   Arboleda, Humberto ^h   Ingelsson, Martin ⁱ   Hyman, Bradley T ^j   Akatsu, Hiroyasu ^k   Grupe, Andrew ^l   Nishimura, Agnes Lumi ^m   Zatz, Mayana ^m   Mattila, Kari M ^n,o   Rinne, Juha ^p   Goto, Yu Ichi ^a   Asada, Takashi ^q   Nakamura, Shun ^a   Kunugi, Hiroshi ^a   more..

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e KURIHAMA NATIONAL HOSPITAL   (Japan)

^f Department of Neurological and Psychiatric Sciences ^*  (Italy)

^g Carlsbad Science Foundation   (United States)

^h UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

ⁱ UPPSALA UNIVERSITY   (Sweden)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k NAGOYA CITY UNIVERSITY   (Japan)

^l CELERA   (United States)

^m UNIVERSITY OF SÃO PAULO   (Brazil)

ⁿ TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^o TAMPERE UNIVERSITY HOSPITAL   (Finland)

^p UNIVERSITY OF TURKU   (Finland)

^q UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

Alzheimer's disease (AD); Brain derived neurotrophic factor (BDNF); Meta analysis; Polymorphism; Sex difference

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STRATIFICATION;

AGED; ALZHEIMER DISEASE; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHIONINE; SEX CHARACTERISTICS; VALINE;

EID: 73949140716     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30986     Document Type: Article

References (52)

1. Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jonsson EG. 2006. BDNF gene variants and brain morphology in schizophrenia. AmJ Med Genet Part B 141B(5):513-523.
2. Akatsu H, Yamagata HD, Kawamata J, Kamino K, TakedaM, Yamamoto T, Miki T, Tooyama I, Shimohama S, Kosaka K. 2006. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn Disord 22(3):216-222.
3. Bagnoli S, Nacmias B, Tedde A, Guarnieri BM, Cellini E, Petruzzi C, Bartoli A, Ortenzi L, Sorbi S. 2004. Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann Neurol 55(3):447-448.
4. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. 2007. Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39(1):17-23.
5. Bian JT, Zhang JW, Zhang ZX, Zhao HL. 2005. Association analysis of brain -derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Neurosci Lett 387(1):11-16.
6. Bodner SM, Berrettini W, van Deerlin V, Bennett DA, Wilson RS, Trojanowski JQ, Arnold SE. 2005. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet Part B 134B(1):1-5.
7. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. 2006. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59(9):812-815.
8. Combarros O, Infante J, Llorca J, Berciano J. 2004. Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 18(1):55-58.
9. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. 1997. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49(1-2):71-81.
10. del Toro D, Canals JM, Gines S, Kojima M, Egea G, Alberch J. 2006. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J Neurosci 26(49):12748-12757.
11. Desai P, Nebes R, DeKosky ST, Kamboh MI. 2005. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci Lett 379(3):229-234.
12. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257-269.
13. Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Marti E. 1999. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58(7):729-739.
14. Foltynie T, Lewis SG, Goldberg TE, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA. 2005. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol 252(7):833-838.
15. Forero DA, Benitez B, Arboleda G, Yunis JJ, Pardo R, Arboleda H. 2006. Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF,COMTANDUCHL1)in Alzheimer's disease in Colombia. Neurosci Res 55(3):334-341.
16. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. 1997. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 48(1):132-138.
17. Frodl T, Schule C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, et al. 2007. Association of the brainderived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64(4):410-416.
18. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311):704-706.
19. He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB, Hong Z. 2007. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population. Neuropsychobiology 55(3-4):151-155.
20. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. 2006. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63(7):731-740.
21. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. 2000. Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57(6):846-851.
22. Huang R, Huang J, Cathcart H, Smith S, Poduslo SE. 2007. Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet 44(2):e66.
23. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, Kobayashi S, Nanko S. 2001. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6(1):83-86.
24. Lee J, Fukumoto H, Orne J, Klucken J, Raju S, Vanderburg CR, Irizarry MC, Hyman BT, Ingelsson M. 2005. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 194(1):91-96.
25. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH,Yu CE, Jondro PD, Schmidt SD,WangK, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269(5226):973-977.
26. Y, Rowland C, Tacey K, Catanese J, Sninsky J, Hardy J, Powell J, Lovestone S, Morris JC, Thal L, et al. 2005. The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Mol Psychiatry 10(9):809-810.
27. Liguori M, Fera F, Gioia MC, Valentino P, Manna I, Condino F, Cerasa A, La Russa A, Clodomiro A, Paolillo A, et al. 2007. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis. Genes Brain Behav 6(2):177-183.
28. Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T, Higuchi S. 2005. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm 112(5):703-711.
29. Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430(7000):631-639.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944.
31. Miranda RC, Sohrabji F, Toran-Allerand CD. 1993. Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions. Proc Natl Acad Sci USA 90(14):6439-6443.
32. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ. 2007. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61(2):187-197.
33. Nacmias B, Piccini C, Bagnoli S, Tedde A, Cellini E, Bracco L, Sorbi S. 2004. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 367(3):379-383.
34. Nemoto K, Ohnishi T, Mori T, Moriguchi Y, Hashimoto R, Asada T, Kunugi H. 2006. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 397(1-2):25-29.
35. Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA, Zatz M. 2004. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J Mol Neurosci 22(3):257-260.
36. Nishimura M, Kuno S, Kaji R, Kawakami H. 2005. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord 20(8):1031-1033.
37. Olin D, MacMurray J, Comings DE. 2005. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett 381(3):275-278.
38. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24(45):10099-11102.
39. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361(1473):1545-1564.
40. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Muller U, Forstl H, Kurz A. 2002. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 7(7):782-785.
41. Saarela MS, Lehtimaki T, Rinne JO, Huhtala H, Rontu R, Hervonen A, Roytta M, Ahonen JP, Mattila KM. 2006. No association between the brain-derived neurotrophic factor 196G>Aor 270C>Tpolymorphisms and Alzheimer's or Parkinson's disease. Folia Neuropathol 44(1):12-16.
42. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43(8):1467-1472.
43. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375(6534):754-760.
44. Sohrabji F, Miranda RC, Toran-Allerand CD. 1995. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92(24):11110-11114.
45. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, et al. 2005. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10(7):631-636.
46. Tsai SJ, Hong CJ, Liu HC, Liu TY, Liou YJ. 2006. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population. Dement Geriatr Cogn Disord 21(3):139-143.
47. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, Gennarelli M. 2002. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 7(2):136-137.
48. Vepsalainen S, Castren E, Helisalmi S, Iivonen S, Mannermaa A, Lehtovirta M,Hanninen T, Soininen H, HiltunenM.2005. Genetic analysis ofBDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol 252(4):423-428.
49. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B. 2008. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: Effects of gender and ethnicity. Mol Psychiatry (in press).
50. Wenham PR, Price WH,Blandell G. 1991. Apolipoprotein E genotyping by one-stage PCR. Lancet 337(8750):1158-1159.
51. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ, Rasmussen A, et al. 2006. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet Part B 141B(4):387-393.
52. Zhang XM, Zhu SW, Duan RS, Mohammed AH, Winblad B, Zhu J. 2008. Gender differences in susceptibility to kainic acid-induced neurodegeneration in aged C57BL/6 mice. Neurotoxicology 29(3):406-412.